STRATA Skin Sciences(SSKN)

Search documents
STRATA Skin Sciences(SSKN) - 2021 Q3 - Quarterly Report
2021-11-12 19:42
OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to ___________ Commission File Number 0-51481 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 STRATA SKIN SCIENCES, INC. (Exact name of registrant as specified in its charter) (215) 619-3200 (Registrant ...
STRATA Skin Sciences(SSKN) - 2021 Q3 - Earnings Call Transcript
2021-11-11 01:49
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Leigh Salvo - IR Robert Moccia - President, CEO & Director Christopher Lesovitz - CFO Conference Call Participants Suraj Kalia - Oppenheimer Jeffrey Cohen - Ladenburg Thalmann & Co. Operator Welcome to the STRATA Skin Sciences Third Quarter 2021 Earnings Conference Call. [Operator Instructions]. I would now like to turn the conference over to Leigh Salvo with Investor Relations. Please ...
STRATA Skin Sciences(SSKN) - 2021 Q2 - Earnings Call Transcript
2021-08-17 01:44
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q2 2021 Earnings Conference Call August 16, 2021 4:30 PM ET Company Participants Leigh Salvo - Gilmartin Group Robert Moccia - President, CEO & Director Matthew Hill - VP & CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann & Co. Suraj Kalia - Oppenheimer Operator Good day, and welcome to the STRATA Skin Sciences' Second Quarter 2021 Earnings Conference Call. [Operator Instructions]. Please note, this conference is being recorded. I would now like to ...
STRATA Skin Sciences(SSKN) - 2021 Q2 - Quarterly Report
2021-08-16 20:52
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to ___________ Commission File Number 0-51481 STRATA SKIN SCIENCES, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisd ...
STRATA Skin Sciences(SSKN) - 2021 Q1 - Quarterly Report
2021-05-13 16:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10 - Q [x] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to ___________ Commission File Number 0-51481 STRATA SKIN SCIENCES, INC. (Exact name of registrant as specified in its charter) Delaware (State or other ...
STRATA Skin Sciences(SSKN) - 2021 Q1 - Earnings Call Transcript
2021-05-13 01:06
Start Time: 16:30 January 1, 0000 5:08 PM ET STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q1 2021 Earnings Conference Call May 12, 2021, 16:30 PM ET Company Participants Robert Moccia - CEO Matthew Hill - CFO Leigh Salvo - IR Conference Call Participants Joseph Pantginis - H.C. Wainwright Jeffrey Cohen - Ladenburg Thalmann Suraj Kalia - Oppenheimer Operator Greetings, and welcome to STRATA Skin Sciences First Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. A ques ...
STRATA Skin Sciences(SSKN) - 2020 Q4 - Annual Report
2021-03-25 17:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to _____________ Commission file number: 0-11635 STRATA SKIN SCIENCES, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation or organization) 13-3986004 (I.R.S. Employer Identification No.) 5 Walnut Grove Drive, Suite 1 ...
STRATA Skin Sciences(SSKN) - 2020 Q4 - Earnings Call Transcript
2021-03-25 02:26
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2020 Earnings Conference Call March 24, 2021 4:30 PM ET Company Participants Leigh Salvo - IR Robert Moccia - President, CEO & Director Matthew Hill - VP & CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann & Co. Suraj Kalia - Oppenheimer Operator Greetings, and welcome to STRATA Skin Sciences Fourth Quarter 2020 Earnings Conference Call. [Operator Instructions]. I will now turn the conference over to your host, Leigh Salvo. You may begin. Leigh S ...
STRATA Skin Sciences(SSKN) - 2020 Q3 - Earnings Call Transcript
2020-11-10 18:52
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q3 2020 Results Earnings Conference Call November 10, 2020 8:30 AM ET Company Participants Leigh Salvo - Investor Relations Dolev Rafaeli - President and Chief Executive Officer Matt Hill - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Suraj Kalia - Oppenheimer & Company Operator Greetings, and welcome to STRATA Skin SciencesÂ' Third Quarter 2020 Earnings Conference Call. [Operator Instructions] As a reminder, this conference ...
STRATA Skin Sciences (SSKN) Investor Presentation - Slideshow
2020-10-13 22:13
| --- | --- | --- | --- | --- | |-------|---------------------------------------|---------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | S e p t e m b e r 2 0 2 0 | | | | | | | | | | | Driving Value to Dermatology Partners | | | | | | | | | | | | | | | | | | | | | | Safe Harbor Statement This presentation includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors. A ...